Literature DB >> 24924851

Can intermittent theta burst stimulation as add-on to psychotherapy improve nicotine abstinence? Results from a pilot study.

Alica C Dieler1, Thomas Dresler, Kathrin Joachim, Jürgen Deckert, Martin J Herrmann, Andreas J Fallgatter.   

Abstract

Smoking is among the leading causes of mortality worldwide. Discontinuing smoking can increase life expectancy to the presmoking level. Unaided attempts are often ineffective, strengthening the necessity of cognitive-behavioral therapy (CBT), nicotine replacement or pharmacotherapy. Still, relapse rates are high. Recently, a modulation of nicotine craving, which predicts relapse, through transcranial magnetic stimulation to the prefrontal cortex was shown. In a pilot study, we investigated whether 4 sessions of intermittent theta burst stimulation (iTBS) as add-on treatment to CBT reduces nicotine craving and improves long-term abstinence (at 3, 6 and 12 months). Smokers were randomly assigned to a treatment (n = 38) or a sham group (n = 36). Although we did not find reduced craving, we could show higher abstinence rates in the treatment group at 3 months. At 6 and 12 months abstinence rates did not differ significantly. Results at 12 months, however, have to be interpreted cautiously due to significant differences in the dropout rates between the two groups at this time point. We provide first evidence for a beneficial effect of additional iTBS on intermediate nicotine abstinence; however, the low number of iTBS sessions might have prevented longer effects. More lasting effects might be achieved by iTBS maintenance sessions in analogy to the treatment of depression.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 24924851     DOI: 10.1159/000357941

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  15 in total

Review 1.  A perfect match: noninvasive brain stimulation and psychotherapy.

Authors:  Malek Bajbouj; Frank Padberg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-25       Impact factor: 5.270

Review 2.  Non-invasive Brain Stimulation for the Treatment of Nicotine Addiction: Potential and Challenges.

Authors:  Li-Zhuang Yang; Zhiyu Yang; Xiaochu Zhang
Journal:  Neurosci Bull       Date:  2016-09-02       Impact factor: 5.203

3.  Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead.

Authors:  Hamed Ekhtiari; Hosna Tavakoli; Giovanni Addolorato; Chris Baeken; Antonello Bonci; Salvatore Campanella; Luis Castelo-Branco; Gaëlle Challet-Bouju; Vincent P Clark; Eric Claus; Pinhas N Dannon; Alessandra Del Felice; Tess den Uyl; Marco Diana; Massimo di Giannantonio; John R Fedota; Paul Fitzgerald; Luigi Gallimberti; Marie Grall-Bronnec; Sarah C Herremans; Martin J Herrmann; Asif Jamil; Eman Khedr; Christos Kouimtsidis; Karolina Kozak; Evgeny Krupitsky; Claus Lamm; William V Lechner; Graziella Madeo; Nastaran Malmir; Giovanni Martinotti; William M McDonald; Chiara Montemitro; Ester M Nakamura-Palacios; Mohammad Nasehi; Xavier Noël; Masoud Nosratabadi; Martin Paulus; Mauro Pettorruso; Basant Pradhan; Samir K Praharaj; Haley Rafferty; Gregory Sahlem; Betty Jo Salmeron; Anne Sauvaget; Renée S Schluter; Carmen Sergiou; Alireza Shahbabaie; Christine Sheffer; Primavera A Spagnolo; Vaughn R Steele; Ti-Fei Yuan; Josanne D M van Dongen; Vincent Van Waes; Ganesan Venkatasubramanian; Antonio Verdejo-García; Ilse Verveer; Justine W Welsh; Michael J Wesley; Katie Witkiewitz; Fatemeh Yavari; Mohammad-Reza Zarrindast; Laurie Zawertailo; Xiaochu Zhang; Yoon-Hee Cha; Tony P George; Flavio Frohlich; Anna E Goudriaan; Shirley Fecteau; Stacey B Daughters; Elliot A Stein; Felipe Fregni; Michael A Nitsche; Abraham Zangen; Marom Bikson; Colleen A Hanlon
Journal:  Neurosci Biobehav Rev       Date:  2019-07-02       Impact factor: 8.989

Review 4.  Transcranial Magnetic Stimulation Treatment for Smoking Cessation: An Introduction for Primary Care Clinicians.

Authors:  Jonathan R Young; Jeffrey T Galla; Lawrence G Appelbaum
Journal:  Am J Med       Date:  2021-08-15       Impact factor: 4.965

5.  Feasibility of a Combined Neuromodulation and Yoga Intervention for Mild Traumatic Brain Injury and Chronic Pain: Protocol for an Open-label Pilot Trial.

Authors:  Kelly A Krese; Kyla Z Donnelly; Bella Etingen; Theresa L Bender Pape; Sarmistha Chaudhuri; Alexandra L Aaronson; Rachana P Shah; Dulal K Bhaumik; Andrea Billups; Sabrina Bedo; Mary Terese Wanicek-Squeo; Sonia Bobra; Amy A Herrold
Journal:  JMIR Res Protoc       Date:  2022-06-15

Review 6.  A review of brain stimulation methods to treat substance use disorders.

Authors:  Alexandria S Coles; Karolina Kozak; Tony P George
Journal:  Am J Addict       Date:  2018-02-19

7.  The two-way relationship between nicotine and cortical activity: a systematic review of neurobiological and treatment aspects.

Authors:  Carlota de Miquel; Benjamin Pross; Irina Papazova; Duygu Güler; Alkomiet Hasan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-06-27       Impact factor: 5.270

Review 8.  Treating cocaine and opioid use disorder with transcranial magnetic stimulation: A path forward.

Authors:  Vaughn R Steele; Andrea M Maxwell
Journal:  Pharmacol Biochem Behav       Date:  2021-07-21       Impact factor: 3.697

9.  Intermittent Theta Burst Stimulation of the Prefrontal Cortex in Cocaine Use Disorder: A Pilot Study.

Authors:  Angela Sanna; Liana Fattore; Paola Badas; Giorgio Corona; Viola Cocco; Marco Diana
Journal:  Front Neurosci       Date:  2019-07-25       Impact factor: 4.677

10.  Efficacy of transcranial direct current stimulation (tDCS) in reducing consumption in patients with alcohol use disorders: study protocol for a randomized controlled trial.

Authors:  Benoit Trojak; Agnès Soudry-Faure; Nicolas Abello; Maud Carpentier; Lysiane Jonval; Coralie Allard; Foroogh Sabsevari; Emilie Blaise; Eddy Ponavoy; Bernard Bonin; Vincent Meille; Jean-Christophe Chauvet-Gelinier
Journal:  Trials       Date:  2016-05-17       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.